A Study of AMDX-2011P in Participants With Primary Open Angle Glaucoma — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Study of AMDX-2011P in Participants With Primary Open Angle Glaucoma — Stella

Recruiting

Back to Primary Open Angle Glaucoma trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(3 sites)

United States

Associated Retina Consultants, Phoenix, Arizona

Global Research Management, Glendale, California

Eye Research Foundation, Newport Beach, California

Key details

Phase

Safety & dosing

Sponsor

Amydis Inc.

Enrollment target

~50 participants

Started

December 2023

Primary completion

November 2024

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

22 Years and older

Last updated July 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov